Amazon Pharmacy Starting Up In India: What Pharma Could Gain Or Lose
Heavyweight Competition In Sight But Scale And Reach On US Entrant's Side?
Executive Summary
Amazon Pharmacy’s debut in India could recalibrate and disrupt drug dispensing and distribution in the country, while also tempering investment flow in the e-pharmacy segment. Some experts also predict a squeeze on pharma’s profits.
You may also be interested in...
Sleeping With The Enemy? Open Minds Needed For Tech Partnerships
The entry of tech giants Amazon and Alphabet into healthcare has the potential to disrupt the industry, but can established pharma players partner with them in the move towards a customer and data-oriented future? Panelists from Gilead, Merck KGaA, Bristol-Myers Squibb and others deliberated the question at a recent summit.
Sleeping With The Enemy? Open Mind Needed For Tech Giant Partnerships
The entry of tech giants Amazon and Alphabet into healthcare has the potential to disrupt the industry, but can established pharma players partner with them in the move towards a customer and data-oriented future? Panelists from Gilead, Merck KGaA, Bristol-Myers Squibb and others deliberated the question at a recent summit.
McKinsey Exec On Pharma's Digital Shift, Deal-Making Expectations
McKinsey India's head of pharmaceutical and healthcare practice shares insights on pharma’s risk management efforts and accelerated deployment of digital technologies, including augmented reality headsets for shop floor operators amid the pandemic. He expects a broad surge in deal-making and says pharma is poised for a “full recovery” soon.
Need a specific report? 1000+ reports available
Buy Reports